Medicine - Health
New measures to treat kidney cancer
The US Food and Drug Administration (FDA) recently approved the use of oral Votrient (pazopanib) to treat end-stage renal cell carcinoma.
Votrient
Browse ScienceInfo articles and explainers related to Votrient.
Topic archive
Articles about Votrient
1 published item.